ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NXL vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY

Nexalin Technology Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: NXL 2 — MRK 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NXL VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NXL MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 79.70% 74.80% +4.90 NXL /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 20.70% -55.70 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield — 3.42% — TIE /fcf-yield <GO>
Operating Margin -60.00% 34.30% -94.30 MRK /operating-margins <GO>
Net Profit Margin -60.00% 28.10% -88.10 MRK /net-margins <GO>
Revenue Growth (YoY) 78.80% 1.30% +77.50 NXL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 5.19 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 7/9 -3.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 26.9 51.7 -24.80 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.9M $361.02B -$361.02B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NXL REV MRK REV NXL GROSS % MRK GROSS % NXL FCF MRK FCF
FY 2025 $301.6K $65.01B 79.7% 74.8% -$5.0M $12.36B
FY 2024 $168.7K $64.17B 78.3% 76.3% -$3.9M $18.10B
FY 2023 $110.7K $60.12B — — -$3.8M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NXL // BETA —
MRK // BETA 0.92